63304-80-3

Basic information

• Product Name: (4-METHOXY-3-NITROPHENYL)ACETIC ACID
• Synonyms: (4-METHOXY-3-NITROPHENYL)ACETIC ACID;4-METHOXY-3-NITRO-BENZENEACETIC ACID;BENZENEACETIC ACID, 4-METHOXY-3-NITRO-;UKRORGSYN-BB BBR-048898
• CAS NO: 63304-80-3
• Molecular Formula: C₉H₉NO₅
• Molecular Weight: 211.17
• Mol File: 63304-80-3.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 421.6 °C at 760 mmHg
• Flash Point: 208.8 °C
• Appearance: /
• Density: 1.382 g/cm³
• Vapor Pressure: 7.35E-08mmHg at 25°C
• Refractive Index: 1.576
• Storage Temp.: 2-8°C
• CAS DataBase Reference: (4-METHOXY-3-NITROPHENYL)ACETIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: (4-METHOXY-3-NITROPHENYL)ACETIC ACID(63304-80-3)
• EPA Substance Registry System: (4-METHOXY-3-NITROPHENYL)ACETIC ACID(63304-80-3)

Safety Data

• Hazardous Substances Data: 63304-80-3(Hazardous Substances Data)

Usage

Uses

(4-Methoxy-3-nitrophenyl)acetic Acid is used in the preparation of penicillins.

InChI:InChI=1/C9H9NO5/c1-15-8-3-2-6(5-9(11)12)4-7(8)10(13)14/h2-4H,5H2,1H3,(H,11,12)

Upstream product

• 904-42-7 2-Phenyl-4-(3-nitro-4-methoxy-benzyliden)-4H-(1,3)-oxazol-5-on 
• 6343-93-7 2-(4-methoxyphenyl)acetamide 
• 34837-88-2 methyl 2-(4-methoxy-3-nitrophenyl)acetate 
• 10463-20-4 4-hydroxy-3-nitrophenylacetic acid 
• 156-38-7 4-hydroxyphenylacetate 
• 74-88-4 methyl iodide 
• 6378-19-4 4-methoxy-3-nitrobenzyl chloride 
• 123-11-5 4-methoxy-benzaldehyde 
• 7664-93-9 sulfuric acid 
• 56245-07-9 2-(4-methoxy-3-nitrophenyl)acetonitrile 
• 64-19-7 acetic acid 
• 857544-00-4 2-(4-methoxy-3-nitrophenyl)acetamide 
• 104-01-8 4-Methoxyphenylacetic acid 

Downstream Products

• 34837-88-2 methyl 2-(4-methoxy-3-nitrophenyl)acetate 
• 63304-81-4 2-(3-amino-4-methoxyphenyl)acetic acid 
• 168766-14-1 2-(4-methoxy-3-nitrophenyl)ethanol 
• 160857-72-7 (4-methoxy-3-nitrophenyl)ketene 
• 857544-00-4 2-(4-methoxy-3-nitrophenyl)acetamide 

Relevant articles and documents

TETRAHYDROISOQUINOLINE COMPOUNDS

The present invention relates to a novel class of tetrahydroisoquinoline compounds of formula I and to compositions comprising the same. The compounds and compositions of the present invention can be used as medicaments in the treatment of cancer.

N2-(2-METHOXYPHENYL)PYRIMIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR CANCER PREVENTION OR TREATMENT CONTAINING SAME AS ACTIVE INGREDIENT

The present invention relates to a N2-(2-methoxyphenyl)pyrimidine derivative, a preparation method thereof, and a pharmaceutical composition for the prevention or treatment of cancer comprising the same as an active ingredient. The N2-(2-methoxyphenyl)pyrimidine derivative, the optical isomer thereof, or the pharmaceutically acceptable salt thereof of the present invention is very effective in suppressing anaplastic lymphoma kinase (ALK) activity and as a result it can improve the effectiveness of treatment on cancer cells having anaplastic lymphoma kinase (ALK) fusion proteins such as EML4-ALK and NPM-ALK, so that it can be effectively used as a pharmaceutical composition for preventing or treating cancer.

Kappa agonist compounds and pharmaceutical formulations thereof

Compounds having kappa opioid agonist activity, compositions containing them and method of using them as analgesics are provided. The compounds of formula IIIB have the structure: wherein R1, R2, R, Ar and n are as described in the specification.